MS
EW icon

Maven Securities’s Edwards Lifesciences EW Stock Holding History

Maven Securities’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,400
Closed -$222K – 952
2024
Q2 		$222K Buy
+2,400
New +$213K ﹤0.01% 862
2023
Q4 		– Sell
-7,000
Closed -$485K – 1007
2023
Q3 		$485K Buy
7,000
+4,200
+150% +$338K 0.01% 816
2023
Q2 		$264K Buy
+2,800
New +$243K ﹤0.01% 765
2022
Q2 		– Sell
-5,800
Closed -$683K – 954
2022
Q1 		$683K Hold
5,800
– – 0.02% 443
2021
Q4 		$751K Sell
5,800
-20,800
-78% -$2.43M 0.02% 435
2021
Q3 		$3.01M Buy
26,600
+8,000
+43% +$913K 0.1% 155
2021
Q2 		$1.93M Buy
18,600
+14,200
+323% +$1.34M 0.08% 245
2021
Q1 		$368K Buy
+4,400
New +$372K 0.02% 760

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Maven Securities's EW Position: Q1 2025 in Review

Maven Securities sold out of Edwards Lifesciences (EW) in Q1 2025, closing a stake of 2,941 shares — an estimated $218K sold.

Maven Securities first reported a position in EW in Q4 2020 and held it in 4 quarters. The position peaked at $1.55M in Q4 2020. 1,204 funds tracked by Wall St. Rank hold EW as of Q1 2025.

  • Maven Securities reported no remaining Edwards Lifesciences position as of Q1 2025 after selling out during the quarter.
  • Maven Securities sold 2,941 Edwards Lifesciences shares in Q1 2025, an estimated $218K.
  • Maven Securities first reported a position in Edwards Lifesciences in Q4 2020 and held it in 4 quarters.
  • Maven Securities's Edwards Lifesciences position peaked at $1.55M in Q4 2020.
  • 1,204 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2025.

Based on Maven Securities's 13F filing for Q1 2025, filed 14 May 2025.